About Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń
During the past decade, Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
2021-01-18
2022-07-14
Completed
69
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" #1 sponsor was "Abbott" with 2 trials, followed by "Sangart" with 2 trials
sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored, "Cell Genesys" with 1 trials sponsored and "Medical University of Lublin"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń"
#1 collaborator was "Allergan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń
According to Clinical.Site data, the most researched conditions in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" are
"Bladder Cancer" (2 trials), "Hypotension" (2 trials), "Ischemia" (2 trials), "Prostate Cancer" (2 trials) and "Cesarean Section" (1 trials). Many other conditions were trialed in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" in a lesser frequency.
Clinical Trials Intervention Types at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń
Most popular intervention types in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" are "Drug" (8 trials), "Biological" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Apaziquone" (2 trials), "Atrasentan" (2 trials), "Hemospan (MP4OX)" (2 trials) and "Voluven (HES 130/0.4)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń
The vast majority of trials in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" are
5 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń
Currently, there are NaN active trials in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".